The incorporation of 1-deazaadenosine (c 1 A, 1b) into a hammerhead ribozyme and the resulting catalytic activity is described. For this purpose the phosphoramidite 2a and the 3′-phosphonate 2b as well as Fractosil-linked 1-deazaadenosine (3b) were prepared. The methoxyacetyl group was used for the 6-amino group protection and the triisopropylsilyl residue was introduced as the 2′-OH protecting group. Replacement of residues A 14 and A 15.1 of the hammerhead ribozyme by 1-deazaadenosine resulted in a significantly reduced catalytic activity. Substitution of the A 6 , A 9 and A 13 residues has only a minor influence. The findings observed on ribozymes modified with 1-deazaadenosine were compared with those containing other adenosine analogues.
INTRODUCTION
Hammerhead ribozymes are small self-cleaving RNA-molecules made up of three base-paired stems flanking a highly conserved central core. Cleavage of the RNA occurs as the result of a transesterification reaction and generates two products: one containing a terminal 5′-hydroxyl group and the second a terminal 2′,3′-cyclic phosphate. Several crystal structures of hammerhead ribozymes have been published. Self cleavage was avoided by (i) methylation of the 2′-hydroxyl group necessary for catalytic activity (1), (ii) incorporation of a 2′-deoxyribonucleoside residue (2) , (iii) the absence of divalent metal ions (3) . The sequencespecific nature of this endoribonuclease activity suggests ribozymes may be therapeutic agents for the inhibition of gene expression (4) .
Despite significant progress and a number of models, the detailed mechanism of the hammerhead ribozyme cleavage is still unknown. The substitution of individual nucleoside residues by nucleoside analogues having a specific base structure, a modified sugar or phosphate residue, has been used to probe the catalytic activity of individual functional groups. The adenosine analogues studied include: (i) purine (5, 6) , (ii) 7-deazaadenosine (tubercidin) (7, 8) and (iii) 3-deazaadenosine (9) . To determine the importance of specific adenosine nitrogen-1 [N(1)] for the catalytic action, adenosine was replaced by 1-deazaadenosine (c 1 A, 1b) (purine numbering is used throughout the discussion section) in the hammerhead ribozyme core (Fig. 1) . By this means the potential N(1) proton acceptor site was removed.
The N(1) of adenosine can participate in a normal A-U Watson-Crick base pair and in a number of unusual inter-and intra-strand hydrogen bonding interactions. These include A-N(1) to G-N(1)H (imino) hydrogen bonds reported for G 5 -A 26 of the high-affinity Rev binding site of the Rev responsive element of the HIV-1 mRNA (10) . The same type of interaction was recently observed in a G-A mismatch of the model duplex (rGCGGACGC) 2 (11) . Intra-strand interaction of the GAAA tetraloop with an RNA helix was first described for the hammerhead system (2) where several adenosine residues form an A-N(1) hydrogen bond with the amino groups of another A-or G-residue and also with the 2′-hydroxyl group of G in the G-C stem. A similar hydrogen bonding was observed in the X-ray structure for the group 1 ribozyme domain (12) for the GAAA tetraloop interactions with an 11 nucleotide tetraloop receptor together with a symmetrical A-A [N(1)-NH 2 ] base pair as a part of the reverse Hoogsteen A-AU base triple. A number of N(1)-A(2′-OH) hydrogen bonds were also observed in this structure.
In the crystal structures of the hammerhead ribozyme inhibitor complexes (1, 2) , only N(1) of the A 14 residue is participating in a hydrogen bond; the N(1) acts as acceptor of the 2′-OH group of the non-conserved U 7 residue. There is no indication based on the X-ray data that N(1) of the conserved adenosine residues A 15.1 , A 13 , A 9 and A 6 is participating in hydrogen bonds.
The 1-deazaadenosine substitution resulted in substantial reductions in the rate of hammerhead cleavage (under singleturnover conditions) when substituted at positions A 15.1 and A 14 (k rel = 0.005, 0.004). This result suggests that the N(1) functional groups at these positions are important in the stabilization of the transition state or conformational intermediate immediately preceding the transition state. These results are not immediately consistent with the current crystal structure models (see discussion below). The A 13 , A 9 and A 6 substitutions resulted in more modest decreases in cleavage rates (k rel = 0.03, 0.1 and 0.03, respectively). We suggest that these reductions in rate are likely the result of indirect effects on ribozyme structure.
RESULTS AND DISCUSSION
Monomer and oligoribonucleotide synthesis 1-Deazaadenosine (1b) was at first prepared by Chatterjee et al. by condensation of the chloromercury derivative of 7-acetamidoimidazo [4,5-b] pyridine with 2,3,5-tri-O-benzoyl-1-chloro-β-Dribofuranose in boiling xylene (13) . This method furnishes N(7) and *To whom correspondence should be addressed. Tel: +1 303 449 6500; Fax: +1 303 449 6995; Email: lnb@rpi.com + Correspondence may also be addressed to this author. Tel: +49 541 969 2814; Fax: +49 541 969 2370; Email: fraseela@rz.uni-osnabrueck.de N(9) regioisomers and results in a low overall yield. Later, De Roos and Salemink synthesized compound 1b by the melting-fusion procedure in a slightly higher yield (14) . Furthermore, Itoh et al. have described another synthesis of 1b starting from imidazo-[4,5-b]pyridine-4-oxide which has been transformed in five steps into the desired 1-deazaadenosine (1b) in a good overall yield (15, 16) . Recently, Cristalli et al. reported a more convenient synthetic route (17) via the SnCl 4 -catalyzed glycosylation of 7-nitroimidazo [4,5-b] pyridine with 1,2,3,5-tetra-O-acetyl-β-Dribofuranose (TAR), followed by the deprotection with methanolic ammonia and reduction of the 6-nitro group. 1-Deazaadenosine (1b), required for this work, was synthesized either according to Mizuno or to Cristalli (Scheme 1). The pK a value of the protonation of 1-deazaadenosine (1b) is 4.7 (18) . The protonation position of compound 1b was determined by 13 C NMR spectroscopy and found to be N(3) ( Table 1) . This was derived from the upfield protonation shifts of the α-carbons next to N(3) while those in β-and γ-position are deshielded (Table 1 ) (19) . The 1-deazaadenosine shows a UV spectrum (MeOH) with two long-wavelength absorption maxima at 264 nm (ε = 12 500) and 280 nm (ε = 10 100). The protonation site of the parent 2′-deoxyadenosine determined by 15 N NMR spectroscopy is N(1) (20) . The pK a value of the protonation is 3.8 (21) .
Oligoribonucleotides containing 1-deazaadenosine were prepared by solid-phase synthesis. For this purpose the building blocks 2a and 2b were synthesized (22, 23) . Earlier, it has been shown that the N-benzoyl group introduced in 1-deaza-2′-deoxyadenosine is a rather stable protecting group and can be removed only with difficulty (24) . Therefore, the methoxyacetyl (mac) and phenoxyacetyl (pac) protecting groups were studied in this case. The mac derivative 4a was obtained via peracylation of compound 1b with methoxyacetyl chloride followed by selective deprotection of the sugar protecting groups with an excess of a pyridine-Et 3 N-H 2 O (1:1:3) (89% yield) (25) . In a similar way, the pac derivative 4b was introduced with phenoxyacetyl anhydride (73% yield). The stability of the protecting groups was measured UV-spectrophotometrically. The half-life time (τ) of 4a (mac) is 17 min, whereas the pac derivative 4b gave a value of 11 min, both measured in 25% aqueous NH 3 solution at 40_C ( Table 2 ). The mac derivative 4a was used for further work. The 4,4′-dimethoxytritylation was introduced under standard conditions furnishing compound 5 (88% yield) (Scheme 2). Commercially available RNA building blocks contain the (tert-butyl)dimethylsilyl (Bu t Me 2 Si) residue as a 2′-OH protecting group (26) . Earlier, Usman et al. (26) and our laboratory (27) introduced the triisopropylsilyl blocking group for the protection of the 2′-hydroxyl of ribonucleosides. In the present study the silylation of 5 with Pr i 3 SiCl (1H-imidazole) led to the formation of the 2′-O-and 3′-O-silyl derivatives 6 and 7 in a ratio of 2.5:1 in 50% total yield (Scheme 3). In agreement with previous observations (27) , silylation of 5 in the presence of AgNO 3 , instead of 1H-imidazole, proceeded with higher regioselectivity with regard to the desired 2′-O-isomer (6, 76% yield and 7, 14% yield). The structures of the regioisomers 6 and 7 were assigned by 1 H, 13 C NMR and 1 H, 1 H NOE difference spectroscopy. The silylation resulted in a 1-2 p.p.m. upfield shift of the particular carbon signal (Table 3) . Upon irradiation of H(4′) of the 2′-O-silylated derivative 6, an NOE of 1.2% was observed on the 3′-hydroxyl group, while irradiation of H(1′) gave no NOE-effect. The 2′-O-silylated derivative 6 displayed the higher TLC mobility compared with the regioisomer 7 as it was previously observed for the other regioisomeric silyl nucleosides (27, 28) .
Phosphitylation of compound 6 was performed according to a described procedure (29 1 H, 13 C and 31 P NMR spectroscopy as well as by elemental analysis. Succinylation of the 3′-O-silyl derivative 7 in the presence of 4-(dimethylamino)pyridine gave derivative 3a (79% yield) which was subsequently activated via the 4-nitrophenyl ester and linked to amino-functionalized Fractosil, yielding 3b. The ligand concentration was found to be 93 µmol/g of solid support. Table 3 . 13 To probe the importance of N(1) of the conserved adenosine residues in the catalytic core of the hammerhead ribozyme, individual adenosine residues from a 53 nucleotide ribozymesubstrate complex were substituted with 1-deazaadenosine. The five base-modified oligonucleotides 8-12 (enzyme strands) were synthesized as well as the substrate strand ( Fig. 1) . Each of these enzyme oligomers contains a single substitution of an adenosine residue with 1-deazaadenosine at the positions A 6 , A 9 , A 13 , A 14 and A 15.1 . Incorporation of 1-deazaadenosine was accomplished by employing the phosphoramidite 2a. The coupling conditions followed a protocol which has recently been described (31) (0.1 M phosphoramidite, 0.1 M S-ethyltetrazole, coupling time = 450 s). The coupling efficiency was >97% which was essentially identical to the commercially available 2′-O-TBDMSi-protected phosphoramidites. The choice of the methoxyacetyl group for amino group protection of the building block 2a proved to be adequate since complete deblocking was achieved with methylamine (65_C, 10 min) as confirmed by the base compositional analysis (Fig. 2 ).
Cleavage activity of the ribozymes modified by 1-deazaadenosine
The five ribozymes with individual substitution at positions A 15.1 , A 14 , A 13 , A 9 and A 6 by 1-deazaadenosine (8) (9) (10) (11) (12) were tested in a cleavage assay containing the complementary 17mer substrate ( Fig. 1 ) under single-turnover conditions. The parent (unmodified) complex of this previously characterized ribozyme (32) showed a cleavage rate of 0.52/min (k obs ). The relative cleavage rates (k rel ) of the base-modified ribozymes are displayed in Figure 1 . The catalytic rate of the ribozymes with substitutions at the residues A 6 , A 13 and A 9 was reduced 10-30-fold while the substitutions of A 14 and A 15.1 resulted in a >200-fold decrease in the cleavage rate. As a control experiment, when the non-conserved position A l2.3 (position within loop II) was substituted no significant decrease in activity was observed. Since the cleavage reactions were performed under single turnover conditions with a large excess of the ribozyme (1 µM = 1000 × K D = 10 × K M of the unmodified ribozyme) and a trace amount of substrate, the observed cleavage rates should approximate the rate of the chemical reaction step (k 2 ). Previous kinetic analysis of the parent ribozyme demonstrated that at this riboyzme concentration the observed rates were log-linear with pH (slope = 1) and magnesium concentrations. Reactions were also performed at 5 µM ribozyme concentration and identical rates were observed, consistent with saturating concentrations of the ribozyme reaction (data not shown).
If the N(1) of the conserved adenosine residues is involved in hydrogen-bonding that is important for the stabilization of the transition state and/or conformational changes towards the transition state, the absence of this acceptor should result in a substantial decrease in k 2 . The magnitude of this decrease should be related to the free energy supplied by the hydrogen bond [∆G = -RT·ln(k 2 )]. The free energy supplied by a hydrogen bond may vary but has been measured to be 0.2-1.5 kcal/mol. One would, therefore, expect a 1.2-5-fold decrease in k 2 . Based upon the above assumptions, a possible explanation for the replacement of adenosine by 1-deazaadenosine would be that each N(1) within the core of the hammerhead is involved in specific interactions, since the cleavage rate always dropped at least 10-fold. On the other hand, this simple explanation is not consistent with the X-ray data and requires further clarification.
There are two factors which should be taken into consideration in the analysis of the activity changes of the modified ribozymes. The first important consideration is that the current crystal structure model very likely represents the 'ground state' of the ribozyme (33) . The interactions between functional groups of the conserved nucleotides that are stabilizing the 'ground state' may differ significantly from the interactions stabilizing the transition state. Therefore, functional groups that are seemingly unimportant in the ground state could have a significant effect in the transition state or accompanying conformational changes. In fact, several functional groups of that type have been identified in the catalytic core of the hammerhead domain through the 'atomic mutagenesis' approach including all functional groups of the guanine at G 5 , as well as nitrogen-3 [N(3)] of the adenine A 15.1 -residues and also of others (33) .
The second important factor that has to be considered in any atomic mutagenesis study relates to non-specific physicochemical changes of the nucleoside residue that result from even single atom substitution. These nonspecific effects can disrupt other interactions and thereby decrease activity. For example, the pK a value of N(3) is altered by the N(1) to C(1) modification. The pK a value of N(3)-protonation of adenosine is 3.5 (34) while that of N(3)-protonation of 1-deazaadenosine is 4.7 (18) . This reflects the higher electron density of the 1-deazaadenine system compared with that of adenine. Additionally, the 6-amino group of 1-deazaadenosine is a more basic residue as in the case of adenosine, therefore acting as a weaker proton donor. This is reflected by the much higher stability of the 1-deazaadenosine amino protecting groups. However, because the cleavage reactions were performed at a pH well above the pK a value of the base (pH 6.5), one would not expect this effect to be substantial. The higher electron density of the 1-deazaadenine system compared with that of adenine could manifest itself in different stacking interactions of the base. Finally, 1-deazadenosine shows a larger preference for a syn-conformation around the glycosidic bond compared with adenosine (35, 36) .
For all of these reasons, it is very difficult to predict the exact magnitude of the decrease in k 2 that results from any single atom modification. However, the ribozymes substituted by 1-deazaadenosine fall into two distinct classes [≤30-fold decrease (A 6 , A 9 , A 13 ) versus >200-fold decrease (A 14 , A 15.1 )]. It is tempting to argue that the removal of the N(1) from A 14 and A 15.1 results from the loss of the H-acceptor site, whereas the removal of the N(1) from A 6 , A 9 and A 13 is due to other phenomena. It is also possible to better separate the specific from non-specific effects by comparing catalytic activities of ribozymes substituted by 1-deazaadenosine with previously characterized ribozymes substituted by other adenosine analogues.
Comparison of the cleavage activity of the c 1 A-modified ribozymes with other base-modified ribozyme molecules
It was reported earlier that 3-deazaadenosine and 7-deazaadenosine at position A 14 results only in a 4-and 8-fold reduction of the cleavage rate (7, 9) . In addition, substitution of the A 14 residue by purine riboside leads only to a 3-7-fold decrease of activity (5, 6) . If the large decrease of the ribozyme activity substituted at A 14 with 1-deazaadenosine (250-fold) is the result of effects not related to hydrogen bonding, one would expect a significant decrease in activity by other base modifications at that position. To the best of our knowledge, the results obtained from ribozymes substituted by 1-deazaadenosine are the first indication that N(1) of A 14 is important for the hammerhead function. In the X-ray structure this nitrogen (A 14 ) participates in a hydrogen bond with the 2′-hydroxyl group of the uridine residue of U 7 . However, a 2′-deoxyuridine replacement at position U 7 has essentially no effect on the catalytic rate as many other 2′-modifications (37). It is therefore very unlikely that the absence of this interaction in the 1-deazadenosine-A 14 mutant results in the observed 250-fold drop in the cleavage activity.
Previous results obtained from the modification at position A 15.1 are somewhat controversial. Fu and McLaughlin (6) reported a 6-fold decrease of the cleavage activity by the incorporation of the purine riboside (nebularine). Slim and Gait (5) found a substantial loss of the activity for this kind of replacement under different cleavage conditions. In our hands, under standard single-turnover conditions, the substitution of A 15.1 by nebularine results in a 30-fold decrease of the cleavage activity (data not shown). The finding that the 1-deazaadenosine incorporation (A 15.1 ) results in a much larger activity loss cannot be simply due to the decreased proton donor capability of the 6-amino group. Surprisingly, in two crystal structures (1,2) an interaction of A 15.1 with U 16.1 was found. A single hydrogen bond is formed between the 6-amino group and O(4). Ruffner and Uhlenbeck (38) demonstrated that any substitution of the A 15.1 -U 16.1 base pair by e.g. a U-A, C-G or G-C pair resulted in complete loss of activity. The incorporation of 7-deazaadenosine at position A 15.1 resulted in a small enhancement of the cleavage activity (7), while the removal of N(3) (3-deazaadenosine) resulted in a large decrease in cleavage rate (9) . Taken together the results argue for direct participation of N(1) and N(3) at position A 15.1 .
The presence of nitrogen-7 at position A 6 was reported to be important for the hammerhead cleavage activity. This was the result of the incorporation of 7-deazaadenosine leading to a 200-fold reduction (8) . On the other hand the incorporation of purine as well as 3-deazaadenosine at the same position leads only to a 1.5-and 4-fold decrease of the activity. This indicates the relative unimportance of these residues (4,5,9). The 30-fold reduction observed after 1-deazaadenosine incorporation falls in between the effects caused by 7-deazaadenosine and 3-deazaadenosine. In the crystal structure, adenosine at A 6 occupies a central position in domain 1 or the 'uridine turn' forming a purine platform A 6 -G 5 near the cleavage site (1,2). The adenine ring of A 6 is involved in perpendicular stacking interactions with the furanose oxygen-4′ of the C 17 residue in the cleavage site with N(1) of A 6 in close proximity to O(4′) of C 17 . The G 5 residue is a well recognized anomaly in attempts to reconcile the results of functional group modifications with the X-ray structures because a large number of modifications at G 5 inhibit hammerhead activity, yet this residue does not interact with any other functional groups of the ribozyme in the published crystal structures. We (39) and others suggested that there is a need for a substantial conformational change with possible rearrangement of domain 1 and especially G 5 in a transition state compared with the ground state of the hammerhead-substrate complex. On the other hand, based on structures of rapidly frozen ribozyme-substrate complexes, Scott et al. (3) argued that small conformational adjustments are sufficient for achieving catalytic conformation. An additional argument for a substantial rearrangement of domain 1 in the hammerhead upon cleavage was recently presented by Simore et al. (40) , based on NMR analysis on the cleaved hammerhead-product complex, where formation of new hydrogen bonds between U 4 and U 7 was observed.
Several factors may contribute to a 30-fold decrease in cleavage activity for 1-deazaadenosine substitution at position A 6 : the altered electron density of the adenine ring in this analog can effect the formation of the A 6 -G 5 purine platform and/or on an aromatic interaction of the adenine ring of A 6 and the furanose oxygen of the C 17 residue at the cleavage site. If we also assume that substantial rearrangement in domain 1 (C 3 -U 7 ) takes place in the transition state, then such a rearrangement will involve the base of A 6 because of its central location. In such a scenario the altered pK a value of the 6-amino group of 1-deazaadenosine can account for the formation of unproductive destabilizing interactions.
At position A 9 the 1-deazadenosine substitution caused the smallest effect (10-fold decrease) in cleavage activity which indicates the relative unimportance of N(1) at this position. Furthermore, it was demonstrated that the 6-amino group, N(3) and N(7) functionalities also have only a modest impact on cleavage activity based on purine (2-fold reduction) 3-deazaadenosine (10-fold reduction ) and 7-deazaadenosine (2-fold reduction) substitutions (4) (5) (6) (7) (8) (9) . This is surprising since an abasic ribose moiety at this conserved position resulted in a >2500-fold reduction in cleavage activity which can be recovered almost completely by adding adenine base in trans, indicating the perfect fit of adenine functionalities (41) .
According to the crystal structures, the adenosine residue at position A 13 is directly involved in the formation of 'GA-shared' base pairs G 12 A 13 -A 9 G 8 . Additional evidence for the formation of these shared G-A base pairs in the solution was recently obtained by NMR spectroscopy (40) . The essential part of these interactions is the stacking of A 9 above A 13 . It was reported (4-9) that 7-and 3-deazaadenosine and purine substitutions at this position resulted in moderate (2-, 8-and 8-fold, respectively) decreases of the cleavage activity. The observed 30-fold decrease in cleavage activity for 1-deazaadenosine substitution at this position probably reflects more drastic changes in the physical properties of this analog. At the same time, the effect does not seem to be large enough to justify direct involvement of N (1) in stabilization of the vital interaction in the transition state. It is more likely that the altered electron density of the purine ring of 1-deazaadenosine destabilizes stacking interactions which are essential for providing correct geometry of the GA-shared pairs G 12 A 13 -A 9 G 8 in catalytically productive intermediate.
CONCLUSION
One of the most powerful and common tools for understanding structure-function relationships of small RNA molecules is the single atom mutagenesis approach. This technique relies upon individually replacing a single atom or functional group within the entire RNA molecule, and then determining the function of that RNA molecule. A single atom mutation is certainly the smallest and most specific mutation possible and one would therefore expect that changes in the function of the RNA could be correlated directly to the atom or functional group that was mutated. Unfortunately, by mutating a single atom many different features of the nucleotide and RNA may change. For example, the properties of adjacent functional groups may be altered (pK a ), the stacking properties (charge distribution, electron density, hydrophobicity) of the base may change, the syn/anti equilibrium about the glycosidic bond can be effected, and finally conformation of the sugar can shift. It is therefore necessary to carefully compare the effect of substituting several different positions and examine the effects of other modifications at the same position to interpret the results.
To elucidate the importance of the N(1) nitrogens of the conserved adenosine residues for hammerhead cleavage, we prepared the phosphoramidite and phosphonate building blocks (2a,2b) of 1-deazaadenosine protected with a methoxyacetyl group at the amino function and the triisopropylsilyl group at the 2′-OH. When this modified nucleoside was placed individually at each of the five conserved adenosine residues, activity always dropped by at least 10-fold. The simplest explanation for this result is that every A-N(1) within the core of the hammerhead ribozyme is involved in a critical interaction. This would be particularly surprising since current structure models and biochemical evidence argue that none of the A-N(1) nitrogens are important for activity. Upon closer examination, however, it is clear that the 1-deazaadenosine substitutions within the core result in two classes of ribozymes: (i) >200-fold decreases in k obs (A 14 and A 15.1 ) and (ii) 10-30-fold decreases in k obs (A 6 , A 9 and A 13 ). Substitution of position A l2.3 outside of the core resulted in <2-fold decrease in k obs . We suggest that all of the 1-deazaadenosine-substituted ribozymes suffer decreases in activity due to indirect changes to the nucleoside. However, because the magnitude of the decrease in k obs for A 14 -and A 15.1 -substituted ribozymes and the results with other ribozymes containing adenosine analogues, we argue that the N(1) nitrogens of A 14 and A 15.1 are involved in critical interactions for stabilizing the transition state or conformational changes immediately preceding the transition state.
MATERIALS AND METHODS

General
TLC. Alumina sheets coated with a 0.2 mm layer of silica gel 60 F 254 (Merck, Germany) . Flash chromatography (FC) was carried out at 0.5 bar.
UV Spectra. Hitachi U-3000 and U-3200 spectrophotometer (Hitachi, Japan).
NMR Spectra. Bruker AC-250 and AMX-500 spectrometers; δ values in p.p.m. relative to tetramethylsilane as internal standard ( 1 H and 13 C) or to external phosphoric acid ( 31 P). The J values are in Hz. The elemental analyses were performed by Mikroanalytisches Laboratorium Beller (Göttingen, Germany).
Oligonucleotide synthesis
The oligoribonucleotides (2.5 µmol scale) were synthesized on polystyrene supports (ABI) on an Applied Biosystems 394 DNA/ RNA synthesizer. Synthesis, deprotection and analysis of the oligoribonucleotides were performed as previously described (30) . The ribozymes were purified on 15% polyacrylamide, TBE (89 mM Tris-borate, 2 mM EDTA) and 7 M urea gels. The full-length RNA was identified by UV shadowing of the gel, passively eluted with 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA, and then concentrated by ethanol precipitation. The final ribozyme concentrations were determined by the UV absorbance using an extinction coefficient of 350/mM/cm at 260 nm.
To verify the incorporation of 1-deazaadenosine, aliquots of purified ribozymes were analyzed by nucleoside composition analysis (34) . Briefly, the modified ribozymes were digested to the ribonucleosides by incubation of 0.3 A 260 units of the oligonucleotide with 10 U of nuclease P1 (Boehringer Mannheim) and 2 U of calf intestinal alkaline phosphatase (Boehringer Mannheim) in 30 mM NaOAc and 1 mM ZnSO 4 , at pH 5.2 (total volume = 100 µl) overnight at 50_C. The digested material was injected directly onto a C18 reverse column (Waters, Symmetry, ODS 4.6 × 250 mm), and the ribonucleotides were separated by a gradient of buffers A (50 mM potassium phosphate, pH 7.0) and B (95% aqueous MeOH); 0-90% B in A over 35 min. The retention times were compared with monomer standards which were independently characterized by NMR. Under these conditions 1-deazaadenosine was eluted with a retention time of 12 min (Fig. 2) .
Substrate cleavage assay
Ribozyme oligonucleotides and 5′-32 P-end-labeled substrates were heated separately in the reaction buffer at 95_C for 1 min, quenched on ice and then equilibrated to the final reaction temperature (37_C) prior to starting reactions. Reactions were carried out with an excess of the enzyme and were initiated by mixing equal volumes (20 µl) of the substrate (final concentration <1 nM) and ribozyme (1 µM) in 50 mM MES pH 6.5, 10 mM MgCl 2 . Aliquots (4 µl) were removed at various times (5 s to 2 h), quenched in 8 µl of formamide loading buffer (95% formamide, 20 mM EDTA) and loaded onto 15% polyacrylamide, TBE (89 mM Tris-borate, 2 mM EDTA) gels containing 7 M urea. The fraction of substrate and product present at each time point was determined by quantitation of scanned images using a Molecular Dynamics PhosphorImager. The ribozyme cleavage rates were obtained from the plots of the fraction of the substrate remaining versus time using a non-linear, least-squares fit to a double exponential curve (KaleidaGraph, Synergy Software, Reading, PA). The initial, fast portion of the curve represented 80-90% of the total reaction; thus the observed cleavage rates (k obs ) were taken from the rate constant for the first exponential. Relative rates of cleavage (k rel ) were calculated by dividing the observed cleavage rate by the cleavage rate of the unmodified ribozyme (0.52/min). The total extent of cleavage was always u70%.
7-(Methoxyacetylamino)-3-(β-D-ribofuranosyl)-3H-imidazo-[4,5-b]pyridine (4a)
1-Deazaadenosine (1b) (15-17) (410 mg, 1.5 mmol) was co-evaporated several times with anhydrous pyridine (20 ml, each), dissolved in dry pyridine (20 ml) and treated with methoxyacetyl chloride (1.1 ml, 12 mmol). After 1.5 h of stirring at room temperature, H 2 O (3 ml) was added to destroy the excess methoxyacetyl chloride. After another 30 min, the solution was evaporated, the residue dissolved in CH 2 Cl 2 (60 ml) and extracted three times with 5% aqueous NaHCO 3 solution followed by H 2 O (30 ml). The organic layer was dried (Na 2 SO 4 ) and evaporated. The oily residue was stirred for 45 min with Et 3 N-pyridine-H 2 O (1:1:3) (70 ml) at room temperature, the solution evaporated, the oily residue was co-evaporated twice with toluene (20 ml, each) 
7-(Phenoxyacetylamino)-3-(β-D-ribofuranosyl)-[4,5-b]-pyridine (4b)
Compound 1b (180 mg, 0.68 mmol) was dried by evaporation (twice) with anhydrous pyridine (10 ml), dissolved in dry pyridine (10 ml), and treated with phenoxyacetic anhydride (1.56 g, 5.45 mmol). After 12 h of stirring at room temperature, H 2 O (2 ml) was added to destroy the anhydride. After another 30 min, the solution was evaporated, the residue was dissolved in CH 2 Cl 2 (10 ml) and extracted three times with 5% aqueous NaHCO 3 followed by H 2 O (50 ml each). The organic layer was dried (Na 2 SO 4 ) and evaporated to dryness. The resulting yellow oil was stirred for 30 min with pyridine-Et 3 N-H 2 O (1:1:3) (40 ml) at room temperature, the solution was evaporated, co-evaporated twice with toluene (20 ml) 
3-[5-O-(4,4′-Dimethoxytriphenylmethyl)-β-D-ribofuranosyl]-7-(methoxyacetylamino)-3H-imidazo[4,5-b]pyridine (5)
Compound 4a (400 mg, 1.2 mmol) was dried by repeated co-evaporation with anhydrous pyridine and dissolved in dry pyridine (5 ml). Then 4,4′-dimethoxytrityl chloride (520 mg, 1.5 mmol) was added and the solution stirred for 3 h under argon at 40_C. The mixture was cooled to room temperature, MeOH (3 ml) was added and the mixture stirred for another 1 h. Then, the solution was reduced to half of the volume, dissolved in CH 2 Cl 2 (50 ml), and extracted three times with 5% aqueous NaHCO 3 solution (20 ml) followed by saturated aqueous NaCl solution (20 ml 
3-{5-O-(4,4′-Dimethoxytriphenylmethyl)-2-O-[tris(1-methylethyl)silyl]-β-D-ribofuranosyl}-7-(methoxyacetylamino)-imidazo[4,5-b]pyridine (6)
Method A. A solution of 5 (315 mg, 0.49 mmol) in dry pyridine (4 ml) was cooled to 0_C, treated with triisopropylsilyl chloride (Pr i 3 SiCl) (130 µl, 0.64 mmol) and 1H-imidazole (67 mg, 0.98 mmol), stirred for 1 h at 0_C and then for 23 h at room temperature, then a second portion of 1H-imidazole (33 mg, 0.47 mmol) and Pr i 3 SiCl (98 µl, 0.49 mmol) was added. The mixture was stirred for 24 h at room temperature. Then 5% aqueous NaHCO 3 solution (20 ml) was added, the solution was extracted with CH 2 Cl 2 (3 × 20 ml), the combined organic layers were dried (Na 2 SO 4 ), filtered and evaporated. The residue was applied to FC (silica gel, 25 × 3 cm, petrolether-EtOAc-CH 2 Cl 2 1:1:1). From the faster migration zone, 6 (195 mg, 50%) was isolated as a colorless foam.
Method B. To a solution of compound 5 (420 mg, 0.66 mmol) in dry pyridine (5 ml), AgNO 3 (170 mg, 1.00 mmol) was added. After 5 min, a solution of Pr i 3 SiCl (150 µl, 0.75 mmol) in dry THF (7 ml) was introduced under exclusion of light and moisture. After 24 h of stirring, a second portion of Pr i 3 SiCl (75 µl, 0.38 mmol) and AgNO 3 (55 mg, 0.32 mmol) was added, and stirring was continued for another 12 h. AgCl was filtered off and the filtrate treated with 5% aqueous NaHCO 3 solution (20 ml). The aqueous layer was extracted (three times) with CH 2 Cl 2 (20 ml). The combined organic layers were washed with H 2 O (30 ml) and saturated aqueous NaCl solution (30 ml), dried (Na 2 SO 4 ) and evaporated to dryness. The residue was applied to FC (silica gel, 25 × 3 cm, petrolether-EtOAc-CH 2 Cl 2 1:1:1). Diisopropylethylamine (460 µl; 2.65 mmol) and (2-cyanoethyl) (N,N-diisopropylamino)-phosphite (230 µl; 1.03 mmol) were added to a flask containing dry THF (5 ml) under argon (syringe). Then, a solution of 6 (400 mg; 0.50 mmol) in dry THF (5 ml) was added, and the reaction mixture was stirred overnight at room temperature. The reaction was monitored by TLC. The reaction mixture was diluted with CH 2 Cl 2 (100 ml) and washed with 5% aqueous NaHCO 3 solution (50 ml) followed by saturated brine (50 ml). The organic layer was dried (Na 2 SO 4 ), evaporated and co-evaporated with dry acetone. The residue was dissolved in diethyl ether. Evaporation yielded the diastereomeric mixture of
